Alpha-2 receptor agonist (clonidine) is combined with antimuscarinic drug (oxibutynin) and is used for the treatment of sialorrhea

Alpha-2 receptor agonist (clonidine) is combined with antimuscarinic drug (oxibutynin) and is used for the treatment of sialorrhea

  • CN 101,400,347 B
  • Filed: 02/12/2007
  • Issued: 01/20/2016
  • Est. Priority Date: 02/13/2006
  • Status: Active Grant
First Claim
Patent Images

1. one kind comprises α

  • 2 adrenoceptor agonists clonidine and antitoxin the product of alkali medicine oxibutynin, its as have more relative to single administration oxibutynin reduce saliva production effect combination formulations with the form used simultaneously or sequentially for reducing saliva production.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×